CASP3 and neoplasm: Thymax pretreatment revealed more marked upregulation in tumor cells for Bax expression by 4.3 fold and caspase-3 by 3.4 fold, while the expression of Bcl-2 was downregulated by 67.9% versus Inocul Control mice.